OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modes of resistance to anti-angiogenic therapy
Gabriele Bergers, Douglas Hanahan
Nature reviews. Cancer (2008) Vol. 8, Iss. 8, pp. 592-603
Open Access | Times Cited: 2806

Showing 1-25 of 2806 citing articles:

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Cell (2011) Vol. 144, Iss. 5, pp. 646-674
Open Access | Times Cited: 59750

Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet, Rakesh K. Jain
Nature (2011) Vol. 473, Iss. 7347, pp. 298-307
Open Access | Times Cited: 4941

Malignant Gliomas in Adults
Patrick Y. Wen, Santosh Kesari
New England Journal of Medicine (2008) Vol. 359, Iss. 5, pp. 492-507
Closed Access | Times Cited: 4047

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen, David R. Macdonald, David A. Reardon, et al.
Journal of Clinical Oncology (2010) Vol. 28, Iss. 11, pp. 1963-1972
Open Access | Times Cited: 3543

Microenvironmental regulation of metastasis
Johanna A. Joyce, Jeffrey W. Pollard
Nature reviews. Cancer (2008) Vol. 9, Iss. 4, pp. 239-252
Open Access | Times Cited: 3513

Basic and Therapeutic Aspects of Angiogenesis
Michael Potente, Holger Gerhardt, Peter Carmeliet
Cell (2011) Vol. 146, Iss. 6, pp. 873-887
Open Access | Times Cited: 2559

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Pàez‐Ribes, Elizabeth Allen, James Hudock, et al.
Cancer Cell (2009) Vol. 15, Iss. 3, pp. 220-231
Open Access | Times Cited: 2305

Renal cell carcinoma
James J. Hsieh, Mark P. Purdue, Sabina Signoretti, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 2070

VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte, Daniel S. Chen, Napoleone Ferrara
Cell (2019) Vol. 176, Iss. 6, pp. 1248-1264
Open Access | Times Cited: 2016

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger, Makoto Tahara, Lori J. Wirth, et al.
New England Journal of Medicine (2015) Vol. 372, Iss. 7, pp. 621-630
Open Access | Times Cited: 1800

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M.L. Ebos, Christina R. Lee, William Cruz‐Muñoz, et al.
Cancer Cell (2009) Vol. 15, Iss. 3, pp. 232-239
Open Access | Times Cited: 1691

Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis, David A. Cheresh
Nature Medicine (2011) Vol. 17, Iss. 11, pp. 1359-1370
Closed Access | Times Cited: 1642

VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis, Daniel J. Hicklin
Nature reviews. Cancer (2008) Vol. 8, Iss. 8, pp. 579-591
Closed Access | Times Cited: 1612

The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch, Munitta Muthana, Seth B. Coffelt, et al.
Nature reviews. Cancer (2008) Vol. 8, Iss. 8, pp. 618-631
Closed Access | Times Cited: 1586

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 5, pp. 325-340
Open Access | Times Cited: 1532

Pre-metastatic niches: organ-specific homes for metastases
Héctor Peinado, Haiying Zhang, Irina Matei, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 302-317
Closed Access | Times Cited: 1528

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet, Rakesh K. Jain
Nature Reviews Drug Discovery (2011) Vol. 10, Iss. 6, pp. 417-427
Closed Access | Times Cited: 1513

Microenvironmental regulation of tumour angiogenesis
Michele De Palma, Daniela Biziato, Tatiana V. Petrova
Nature reviews. Cancer (2017) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 1512

Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 9, pp. 1745-1770
Open Access | Times Cited: 1426

Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard, Bruno Larrivée
Angiogenesis (2017) Vol. 20, Iss. 4, pp. 409-426
Closed Access | Times Cited: 1235

Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M. Wilhelm, Jacques Dumas, Lila Adnane, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 1, pp. 245-255
Open Access | Times Cited: 1230

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes, Jason Chen, Jenny Tan, et al.
Molecular Cancer Therapeutics (2011) Vol. 10, Iss. 12, pp. 2298-2308
Open Access | Times Cited: 1178

Hallmarks of cancer: Interactions with the tumor stroma
Kristian Pietras, Arne Östman
Experimental Cell Research (2010) Vol. 316, Iss. 8, pp. 1324-1331
Closed Access | Times Cited: 1110

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Jaafar Bennouna, Javier Sastre, Dirk Arnold, et al.
The Lancet Oncology (2012) Vol. 14, Iss. 1, pp. 29-37
Closed Access | Times Cited: 1105

Hypoxia-Induced Angiogenesis: Good and Evil
Bryan L. Krock, N. Skuli, M. Celeste Simon
Genes & Cancer (2011) Vol. 2, Iss. 12, pp. 1117-1133
Open Access | Times Cited: 1077

Page 1 - Next Page

Scroll to top